Kolexia
Reynaud Quitterie Médecine interne
Reynaud Quitterie
Médecine interne
Hôpital Lyon Sud
Pierre-Bénite, France
137 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mucoviscidose Fibrose Diabète Intolérance au glucose Maladies auto-immunes Maladies pulmonaires Vascularite Artérite Lupus érythémateux disséminé

Collaborateurs

Voir plus
Durieu Isabelle
Durieu Isabelle
Hôpital Lyon Sud, Pierre-Bénite, France
Durupt Stephane
Durupt Stephane
Medipole Hopital Mutualiste, Villeurbanne, France
Lega Jean-Christophe
Lega Jean-Christophe
Hôpital Lyon Sud, Pierre-Bénite, France
Nove Josserand Raphaele
Nove Josserand Raphaele
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Sanofi
1 collaboration(s)
Dernière en 2023
Vertex
1 collaboration(s)
Dernière en 2023
VIATRIS SANTE
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
CAESAR: Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis: Multicenter, Prospective, Placebo-controlled, Randomized Trial
Essai Clinique (Hospices Civils de Lyon)   05 mars 2024
I GET DRY: Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Essai Clinique (CHU Saint-Étienne)   01 mars 2024
Facteurs de risque cardiovasculaire spécifiques au cours du lupus érythémateux systémique
87e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 décembre 2023
Extra respiratory comorbidities in adult patients with cystic fibrosis.
European journal of internal medicine   01 novembre 2023
MUKADO: Peer-supporting for Teenagers With Cystic Fibrosis in a Process of Transition of Care From Paediatric to Adult Services : a Mixed-method Pilot Study to Assess the Feasibility of the Peer-support Intervention
Essai Clinique (Hospices Civils de Lyon)   07 août 2023
P308 Strategies for the screening of glucose tolerance abnormalities and diabetes in people with cystic fibrosis: a French position statement
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
EPS6.10 Evolution of psychic symptoms before and after 6 months of treatment with elexacaftor/tezacaftor/ivacaftor (ETI) in French adults patients with cystic fibrosis (pwCF)
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
P126 Health care resource use (HCRU) and associated costs preceding lung transplantation (LT) in Cystic Fibrosis patients
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
P130 Exploring consequences of highly effective modulator therapy on patient’s health pathways and cares in cystic fibrosis centers and beyond by a nationwide research programme in France (HORIZON)
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
ProspeC-F: Identification of Dysglycemia With Continuous Glucose Monitoring: A Prospective Study to Assess the Relationship With Clinical Evolution in Cystic Fibrosis
Essai Clinique (Institut de Recherches Cliniques de Montreal)   24 avril 2023